Trial intelligence / Profile preview

Bone Marrow Aspirate Injections in Knee Arthroscopy

NCT06893302Recruiting

Sponsor
Hospital for Special Surgery
Start
Feb 2026
Primary completion
Apr 2029
Modality
Stem Cell Therapies
Countries
1
01

Overview

Randomised, single-blind trial of bone marrow aspirate in meniscal tear, Chondral defect and osteoarthritis (OA) (2 arms), sponsored by Hospital for Special Surgery. Primary endpoint: Knee Injury and Osteoarthritis Outcome Score at 12 months. Started Feb 2026; status: recruiting.

02

Drugs

bone marrow aspirate
03

Conditions

meniscal tearChondral defectosteoarthritis (OA)

Beyond the preview

Go deeper on NCT06893302.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06893302.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call